[an error occurred while processing this directive]
Research Management Group (RMG)

NIH Funding Opportunities, Resources and Search Tools

 

NIH Search tools and miscellaneous resources



NIH Funding Opportunities



 

 

"Using assist to prepare proposals" workshop materials

 

 

"Using ASSIST to Prepare Proposals" Workshop Materials

Top

 



NIH Investigator-initiated research Parent program announcements


 


You are strongly encouraged to discuss your research project with the institute’s scientific program official.


NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) PA-19-056
Multiple participating institutes (NCI participates in this FOA.) NEI will now participate in this FOA.
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-19-056.html
Table of Institute/Center Program Officer contacts (the webpage reflects the previous FOA#):
https://grants.nih.gov/grants/guide/contacts/parent_R01.html

 

 

NIH Research Project Grant (Parent R01 Clinical Trial Required) P A-19-055
Multiple participating institutes (NCI does not participate in this FOA.) NEI has withdrawn from this FOA.
NIMH is now participating in this FOA.
Eligibility: faculty with PI eligibility and CE faculty with an approved CE faculty PI waiver
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-19-055.html
Table of Institute/Center Program Officer contacts (the webpage reflects the previous FOA#):
https://grants.nih.gov/grants/guide/contacts/Clinical-Trial-Parent-R01.html

 

 

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-19-053 
Multiple participating institutes
Eligibility: faculty with PI eligibility and CE faculty with an approved CE faculty PI waiver
Standard R21 deadlines:   Feb. 16, June 16, Oct. 16
AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program guidelines:
https://grants.nih.gov/grants/guide/pa-files/PA-19-053.html
Table of institute/center program officer contacts (the webpage reflects the previous FOA#):
https://grants.nih.gov/grants/guide/contacts/parent_R21.html

 

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-19-054
Multiple participating institutes. NIMH is now participating in this FOA.
Eligibility: faculty with PI eligibility and CE faculty with an approved CE faculty PI waiver
Standard R21 exploratory/developmental deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-19-054.html
Table of Institute/Center Program contacts (the webpage reflects the previous FOA#)
https://grants.nih.gov/grants/guide/contacts/Clinical-Trial-Parent-R21.html



NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) PA-19-052
Multiple participating institutes
Eligibility: faculty with PI eligibility and CE faculty with an approved CE faculty PI waiver
Standard R03 deadlines:   Feb. 16, June 16, Oct. 16
AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program guidelines:
https://grants.nih.gov/grants/guide/pa-files/PA-19-052.html
Table of institute/center program officials (this webpage reflects the previous FOA#)
https://grants.nih.gov/grants/guide/contacts/parent_R03.html

 


NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648

Multiple participating institutes
Standard R13 deadlines: April 12, Aug. 12, Dec. 12
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-648.html
Table of institute/center program officials (this reflects the previous FOA)
https://grants.nih.gov/grants/guide/contacts/parent_R13_U13.html

 

Top

 

 

 


NIH high risk, high reward programs



Limited submission program- DP5 program:



Unlimited numbers of applicants are permitted for these DP1, DP2, TRA programs:

 

 

The High-Risk, High-Reward Research program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages women and members of groups that are underrepresented in NIH-funded research to apply.


Limited submission- NIH DP5 Award

 

NIH Director's Early Independence Awards (DP5) RFA-RM-19-008
*Request for Nominations from all Schools*
Limited-only TWO applicants are permitted so a university-wide internal selection process is required.
Amount of funding:
 $250,000 direct costs /yr (plus indirect costs) x 5 yrs. ($1.25 million in total direct costs plus indirects)
Purpose: The NIH Director’s Early Independence Awards provide an opportunity for exceptional junior scientists to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. 
Eligibility:
Given the focus on early research independence, the receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2018 and September 30, 2020. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods.  At the time of application (Sept. 13, 2019), the PD/PI must not have served as a post-doctoral fellow following a previous (not the most recent) doctoral degree for more than twelve months.  In addition, at time of application, candidates must not be in an independent position (as defined on the webpage below).
Please see the additonal eligibility criteria on the webpage below.
Internal deadline-EXTENDED: Tuesday, July 9, 2019, 5 p.m.
Internal submission guidelines  

 

 

Unlimited #s of applicants are permitted for these programs:

 

NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) RFA-RM-19-006
Office of Strategic Coordination (Common Fund)
Unlimited #s of applicants are permitted
Amount of funding: Awards will be up to $1,500,000 in direct costs (the equivalent of $300,000 in Direct Costs each year for five years) Awards are multi-year funded with all funds disbursed in the first year of the award.
Eligibility: Stanford assistant professors with PI eligibility and CE assistant professors (with an approved CE faculty PI waiver) who meet the NIH definition of early stage investigator (defined as those who have not received an NIH R01 or similar grant and are within 10 years of completing their terminal research degree or medical residency). (see the guidelines for other criteria)
Single PI applications only.
Timeline:
SoM PIs-
must submit a Proposal Intake Form (PIF) in SeRA  at least a month prior to the sponsor's deadline
Institutional representative (RPM/RMG or CGO/OSR) complete by date: August 19, 2019
Application receipt: August 26, 2019
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-006.html
FAQs: https://commonfund.nih.gov/newinnovator/faq




NIH Director's Pioneer Award (DP1 Clinical Trial Optional) (RFA-RM-19-005)
Office of Strategic Coordination (Common Fund)
Unlimited #s of applicants are permitted
Amount of funding:  $700,000 in direct costs per year (plus indirects) for 5 years ($3.5 million total direct costs)
NIH intends to commit approximately $8,000,000 to fund approximately 7 awards.
Purpose: supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. Funds applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere
Eligibility:  faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) at any career stage.
Single PI application only .
Timeline:
SoM PIs-
must submit a Proposal Intake Form (PIF) in SeRA  at least a month prior to the sponsor's deadline
New date-Institutional representative (RPM/RMG or CGO/OSR) complete by date:  Aug. 30, 2019
NEW Application receipt date: Sept. 6, 2019
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-005.html
FAQs: https://commonfund.nih.gov/pioneer/faq






NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional) RFA-RM-19-007
NIH Roadmap Initiatives
Unlimited #s of applicants are permitted
Amount of funding:   Application budgets are not limited but need to reflect the actual needs of the proposed project.
NIH Common Fund intends to commit approximately $8 million dollars to fund 7 awards, depending on the size and scope of the most meritorious awards.
Purpose: supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Open to scientists at any career stage
Single-PI applications and multi-PI applications welcome
Timeline:
SoM PIs-
must submit a Proposal Intake Form (PIF) in SeRA at least a month prior to the sponsor's deadline
Institutional representatives (RPM/RMG or CGO/OSR) deadline:  Sept. 13, 2019
Application receipt: Sept. 20, 2019
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-007.html
FAQs: https://commonfund.nih.gov/TRA/faq

 

NIH High Risk, High Reward Program Officer-Presentation
Seminar was held on July 16, 2015
Guest speaker: Dr. Ravi Basavappa, NIH Program Leader
Download presentation PDF fle


Award recipients:

Stanford DP1 recipients:
2 in 2018; 2 in 2017; 0 in 2016; 1 in 2015; 1 in 2014; 1 in 2013; 2 in 2012; 1 in 2011
Congratulations to Stanford’s 2018 Pioneer award recipients: Dr. Christine Curtis and Dr. Michelle Monje.
Pioneer award recipient webpage >>

Stanford DP2 recipients:
2 in 2018; 1 in 2017; 6 in 2016*; 6 in 2015**; 1 in 2014; 3 in 2013; 4 in 2012; 1 in 2011
Congratulations to Stanford's New Innovator Award recipient: Dr. Alistair Boettiger.
New Innovator Award recipient webpage >>

Stanford DP5 recipients
0 in 2018; 1 in 2017; 1 in 2016; 0 in 2015; 2 in 2014; 0 in 2013; 2 in 2012; 1 in 2011
(this is a limited submission program-an internal selection process is required)
NIH Early Independence Award recipient webpage >>

Stanford Transformative Award recipients:
4 in 2018; 0 in 2017; 0 in 2016; 0 in 2015; 0 in 2014; 0 in 2013, 3 in 2012; 2 in 2011; 2 in 2010; 4 in 2009
Congratulations to Stanford's 2018 Transformative Award recipients: Dr. Anne Brunet, Dr. Karl Deisseroth, Dr. Roger Kornberg, Dr. Alice Ting
Transformative Research Award recipient webpage >>

 

Top

 

 

Special nih announcements


 

NIH NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed) (RFA-ES-19-007)
National Institute of Environmental Health Sciences
R35-Outstanding Research Investigator
Amount of funding: This FOA seeks to combine their existing investigator-initiated research into a single award with a duration of up to 8 years and direct costs of $600,000 and potentially up to $750,000 based on current NIEHS funding to be consolidated into the award.
This program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts
Application Receipt Date(s): June 20, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-007.html

 

 

NIH NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Basic Experimental Studies with Humans* Required) (RFA-ES-19-008)
National Institute of Environmental Health Sciences
R35-Outstanding Research Investigator
Amount of funding: This FOA seeks to combine their existing investigator-initiated research into a single award with a duration of up to 8 years and direct costs of $600,000 and potentially up to $750,000 based on current NIEHS funding to be consolidated into the award.
*This is intended for basic experimental studies with humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants”. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that fit within this FOA include studies using human subjects to support a deeper understanding of the mechanisms underlying the effects of environmental exposures on human health, including molecular epidemiological studies.
Application Receipt Date(s): June 20, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-008.html

 

 

NIH NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01) (RFA-MH-18-200)
National Institute of Mental Health
$1.625M direct costs over 5 years
Eligibility: Applicants must be designated Early Stage Investigators (ESI) by NIH as defined in NOT-OD-09-013. In addition, applicants must have a tenure track or equivalent Assistant Professor faculty appointment and have a research or health professional level degree (e.g., Ph.D., M.D., or equivalent) at the time of application.
Application Receipt Date(s):
June 20, 2019
Guidelines:
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-200.html

 

 

NIH NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3-Clinical Trial Optional) (RFA-DA-18-020)
National Institute on Drug Abuse
Application budgets are limited to $1,000,000 direct costs per year. (2 awards to be made in FY 17).
The project period is limited to 2 years for the UG3 phase and 3 years for the UH3 phase.
To support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum.
Application Receipt Date(s): July 25, 2019, July 25, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-020.html

 



NIH NINDS Research Program Award (R35 Clinical Trial Optional) (RFA-NS-19-037)

National Institute of Neurological Disorders and Stroke
R35- Outstanding Investigator Award mechanism
The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors (PDs) Principal Investigators (PIs) whose records of research achievement demonstrate their ability to make major contributions to neuroscience. Funding stability for up to eight years. The initial budget period will be five years, with an additional three years granted contingent upon an administrative review.See the guidelines for other criteria.
Eligibility to apply through this FOA is limited to PDs/PIs who have had at least one of the following types of active NINDS grants in each of the past 5 years (that is FY15-19), with no more than one of those years in a no cost extension: R00, R01, R37, R56, DP1, DP2.
Application Receipt Date(s): July 30, 2019
Guidelines:
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-037.html

 

 

NIH NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1-Clinical Trials Optional) (RFA-DA-18-019)
National Institute on Drug Abuse
$500,000 direct costs per year x 5 years ($2.5M total direct costs)
This program is designed to support individual scientists of exceptional creativity who propose cutting edge – and possibly transformative – approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse.
Application Receipt Date(s): August 14, 2019; August 14, 2020
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-019.html

 

 

NIH NIGMS Maximizing Investigators' Research Award for Early Stage Investigators (R35) (PAR-17-190)
National Institute of General Medical Sciences
R35- Outstanding Investigator Award Mechanism
Up to $250K direct costs (plus indirect costs) per year for up to 5 years.
To provide support for the program of research in an *early stage investigator’s (ESI) laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS.
Eligibility: Stanford assist. prof. with PI eligibility who meet the ESI definition*.
PD/PIs are required to devote at least 51% of their time available for research to this award. The time available for research should be expressed in person-months and should not include effort expended toward teaching, administration and/or clinical duties. See other criteria.
Application Receipt/Submission Date(s):  October 3, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-17-190.html

 

 

NIH NIDA Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) (PAR-19-223) 
National Institute on Drug Abuse
Amount of funding:  $300,000 direct costs per year (plus indirects) x 5 years
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field.  
Applicants must meet the definition of an Early Stage Investigator (ESI). An ESI is a new investigator (defined as a PD/PI who has not completed successfully for a significant NIH independent research award) who is within 10 years of completing his/her terminal research degree or is within 10 years of completing medical residency (or the equivalent)
Application Receipt/Submission Date(s): October 21, 2019, October 19, 2020, October 19, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PAR-19-223.html

 

Top




NIH Instrumentation grants (s10) - Internal vetting process required - 2019

 

The required internal vetting process deadline has passed for these 2019 NIH S10 programs. These programs are offered annually.

 

 

NIH High End Instrumentation Grant (HEI) (S10) PAR-19-177
This program accepts applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001 direct costs. The maximum award is $2,000,000 direct costs.
PI eligibility: see the webpage below for PI eligibility, major and minor user group requirements, etc.
**Required: The PD/PI chosen for this application should have documented (in the biographical sketch) technical expertise directly related to the type of the chosen instrument.
The PD/PI does not need to have an NIH research grant or any other research support but is expected to be an expert on the requested instrument. The PD/PI may be a Core director** or non-tenured faculty member of the applicant organization. [**In order to be PI for for this HEI grant, the Core Director must submit a special Rare Exception PI waiver request to Jeanne Heschele by March 114th.**]
TIMELINE:
Required-Submit request for a list of similar instruments* from Stan Dunn in the Property Management Office: Deadline March 8, 2019
*this list, and your response to their findings, are required for the internal vetting process (for instructions, see #4-List of Similar Instruments under the internal vetting process guidelines on the webpage below)
Rare Exception-PI waiver-Core Director request packet* deadline: March 14, 2019
[*download the PDF file of the instructions under eligibility on the webpage below and submit the waiver request to Jeanne Heschele, not your RPM)
Internal vetting process deadline*: Tuesday, March 19, 2019
NIH HEI (S10) Program overview, eligibility, and internal vetting process guidelines:
http://med.stanford.edu/rmg/funding/nih_hei.html

 


NIH Shared Instrumentation Grant (SIG) (S10) PAR-19-179
This program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000. The maximum award is $600,000.
PI eligibility: see the webpage below for PI eligibility, major and minor user group requirements, etc.
**Required: The PD/PI chosen for this application should have documented (in the biographical sketch) technical expertise directly related to the type of the chosen instrument.
The PD/PI does not need to have an NIH research grant or any other research support but is expected to be an expert on the requested instrument. The PD/PI may be a Core director** or non-tenured faculty member of the applicant organization.[**In order to be PI for for this SIG grant, the Core Director must submit a special Rare Exception PI waiver request to Jeanne Heschele by March 14th**]
TIMELINE:
Required-Submit request for a list of similar instruments* from Stan Dunn in the Property Management Office: Deadline March 8, 2019
*this list, and your response to their findings, are required for the internal vetting process (for instructions, see #4-List of Similar Instruments under the internal vetting process guidelines on the webpage below)
Rare Exception-PI waiver-Core Director request packet** deadline: March 14, 2019
[**download the PDF file of the instructions under eligibility on the webpage below and submit the waiver request to Jeanne Heschele, not your RPM)
Internal vetting process deadline*: Tuesday, March 19, 2019
NIH SIG (S10) Program overview, eligibility, and internal vetting process guidelines:
http://med.stanford.edu/rmg/funding/nih_sig.html

 

NIH Shared Instrumentation for Animal Research (SIFAR) Grant (S10) PAR-19-178
This funding opportunity announcement (FOA) does NOT support requests for single instruments. This FOA invites groups of NIH-funded investigators engaged in biomedical research using animals, to seek support for high-cost, state-of-the-art, commercially available scientific instruments. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as a series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations.
At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.
PI eligibility: see the webpage below for PI eligibility, major and minor user group requirements, etc.
**Required: the PI chosen for this application should have documented (in the biographical sketch) technical expertise directly related to the requested instrumentation or scientific expertise in biomedical research using animals.
The PD/PI does not need to have an NIH research grant or any other research support, and may be a Core director**, tenured or non-tenured faculty member of the applicant organization. [**In order to be PI for for this SIG grant, the Core Director must submit a special Rare Exception PI waiver request to Jeanne Heschele by March 14th**.]
TIMELINE:
Required-Submit request for a list of similar instruments* from Stan Dunn in the Property Management Office: Deadline March 8, 2019
*this list, and your response to their findings, are required for the internal vetting process (for instructions, see #4-List of Similar Instruments under the internal vetting process guidelines on the webpage below)
Rare Exception-PI waiver-Core Director request packet** deadline: March 14, 2019
[**download the PDF file of the instructions under eligibility on the webpage below and submit the waiver request to Jeanne Heschele, not your RPM)
Internal vetting process deadline*: Tuesday, March 19, 2019
NIH SIFAR (S10) Program overview, eligibility, and internal vetting process guidelines:

http://med.stanford.edu/rmg/funding/nih_sifar.html

 

 


NIH and AHRQ R36 DISSERTATION GRANTS



Institutional representatives for your R36 application:

School of Medicine PIs:  
Please alert your department's Research Process Manager (RPM) at least 3-4 weeks prior to the sponsor's deadline so that your budget can be completed 10 days prior to the deadline. RPM department assignment webpage>>
SoM Internal proposal deadline policy, best practices and FAQs webpage >>

PIs in Other schools:

Download the Pre-award OSR department assignments, Office of Sponsored Research (OSR) internal proposal deadline policy on this DoResearch webpage >>



R36 Program Announcements:

 


NOTE:
Applicants are strongly encouraged to contact the Scientific Program officer in the program announcement to discuss their dissertation project and eligibility.

 


AHRQ Grants for Health Services Research Dissertation Program (R36) (PA-18-765)
Agency for Healthcare Research and Quality
Purpose: provides support to individuals who are conducting research undertaken as part of an accredited academic program to qualify for a research doctorate degree
Applications for dissertation research grants must be responsive to AHRQ’s mission, AHRQ’s specific priority areas of focus are: Improve health care quality by accelerating implementation of Patient Centered Outcomes Research (PCOR); Make health care safer; Increase accessibility by evaluating expansions of insurance coverage; Improve health care affordability, efficiency and cost transparency
Eligibility:
Candidates are eligible to apply for this award provided that they:
Are U.S. citizens, non-citizen nationals, or permanent residents by the time of the grant award;
Are full-time students (as defined by the student's institution) in good standing, who are enrolled in an accredited research doctoral program in such fields as behavioral sciences, health services research, nursing, social sciences, epidemiology, biostatistics, health policy, health informatics, engineering, and mathematics; Will have completed all non-dissertation requirements for their doctoral degree by the time of submission of the application, including completion of their qualifying exams. The only exception allowed will be the completion of required clinical internships that follow completion of the dissertation.
As noted in the guidelines, individuals supported under NRSA mechanisms, including T32, F31 and F32 research training awards are eligible to apply for an AHRQ dissertation award. 
Application Receipt/Submission Date(s):
February 1, May 1, August 1, and November 1
Expiration date: May 2, 2023
Guidelines
https://grants.nih.gov/grants/guide/pa-files/PA-18-765.html
Institutional representative- RPM/RMG and SoM internal proposal deadline policy see above >>

 



NIDA Drug Abuse Dissertation Research (R36) (PA-16-443)

National Institute on Drug Abuse
The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. This award is for up to two years of support for the completion of the doctoral dissertation research project.
Eligibility: The PD/PI must have an appointment at the applicant institution (e.g., research assistant). Eligible PD/PIs are predoctoral students at the dissertation stage of training with the skills, knowledge, and resources necessary to carry out the proposed research. The applicant must have an approved dissertation proposal (at the time of award), show evidence of high academic performance in the sciences, and a commitment to a career as an independent research scientist, or as an independent physician-scientist or other clinician-scientist (dual-degree training).
The applicant must be currently enrolled in a PhD or equivalent research degree program (e.g., EngD, DNSc, DrPH, DSW, PharmD, PsyD, ScD), a formally combined MD/PhD program, or other combined professional/clinical and research doctoral (e.g., DDS/PhD) in the biomedical, behavioral, or clinical sciences.
For the purpose of this announcement, institutions must identify applicants who will enhance diversity on a national basis as defined in the program announcement.
Citizenship: U.S. citizenship or permanent residency required.
See the guidelines for eligibility criteria.
Standard R36 deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Jan. 8, 2020
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PA-16-443.html
Institutional representative- RPM/RMG and SoM internal proposal deadline policy see above >>





NIH NIMH Mental Health Research Dissertation Grant to Increase Diversity (R36 Independent Clinical Trial Not Allowed) (PAR-18-894) 
National Institute of Mental Health (NIMH)
To increase the diversity of the mental health research workforce by providing dissertation awards in all areas of research within the strategic priorities of the NIMH to individuals from diverse backgrounds underrepresented in mental health research to support the completion of the doctoral research project.
Eligibility: Individuals are eligible to apply for this award provided that they: are registered in an accredited research doctoral degree program; are in good-standing in that program; have an approved dissertation proposal at the time of the award; are U.S. citizens, non-citizen nationals (e.g., residents of U.S. territories), or permanent residents by the time of award.
Remaining Application Receipt/Submission Date(s):  August 06, 2019, December 06, 2019, April 07, 2020, August 06, 2020, December 07, 2020, April 06, 2021
Guidelines:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-894.html
Institutional representative- RPM/RMG and SoM internal proposal deadline policy see above >>
NIH Notice NOT-MH-19-035 re: PAR-18-894- clarificationto the award budget.

 

 

NIH NIA Aging Research Dissertation Awards to Increase Diversity (R36) (PAR-17-025)
National Institute on Aging
To provide dissertation awards in all areas of research within NIA’s strategic priorities to increase diversity of the scientific research workforce engaged in research on aging and aging-related health conditions.
Eligibility: The applicant must have a baccalaureate degree and be enrolled in a Ph.D. or equivalent doctoral-degree program (e.g., Dr. PH., D.NSC. and Sc.D.), a formally combined M.D./Ph.D. program or other combined professional/clinical and research doctoral program in the biomedical, behavioral and social, and clinical sciences at an accredited domestic institution.
For the purpose of this announcement, institutions must identify applicants who will enhance diversity on a national basis as defined under “Eligible individuals” in the program announcement.
Citizenship: Are U.S. citizens, non-citizen nationals, or permanent residents by the time of the grant award
Standard R36 deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Jan. 8, 2020
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-025.html
Institutional representative- RPM/RMG and SoM internal proposal deadline policy see above >>

 

 

 

 


 

NIH Loan repayment program

 

 

NIH Extramural Loan Repayment Programs
Clinical Researchers (LRP-CR)
Clinical Researchers from Disadvantaged Backgrounds (LRP-IDB)
Pediatric Research (LRP-PR)
Contraception and Infertility Research (LRP-CIR)
Health Disparities Research (LRP-HDR)
Eligible positions: for residents, postdoctoral fellows, medical fellows, basic life science staff/research associates, Instructors and assistant professors who meet the eligibility criteria

This webpage >> is for your reference only as it contains the 2017 information.

 

top Top





NIH Updates, policy highlights and quick links to nih websites

 

Clinical Trial Requirements for Grants and Contracts webpage:
Update per the RMG management: enforcement delayed by Congress as part of Consolidated Appropriation Act, 2018 (this webpage does not state this):
https://grants.nih.gov/policy/clinical-trials.htm


Guidance on Salary Limitation for Grants and Cooperative Agreements FY2018

(NOT-OD-18-137) Office of the Director, NIH



NIH Policy on Good Clinical Practice Training for NIH Awardees Involved in NIH-funding Clinical Trials
The NIH released a notice about GCP training for NIH-funded clinical trial investigators and staff that went into effect in Jan. 2017. Stanford’s Collaborative IRB Training Initiative (CITI) includes modules in good clinical practice. See this webpage: http://med.stanford.edu/rmg/resources.html#GCP


Biographical Sketch Format
with instructions, and samples:

https://grants.nih.gov/grants/forms/biosketch.htm

 

NIH Public Access Policy and compliance (and how it impacts your funding)
RMG overview webpage

NIH Policy on on Genomics Data Sharing
Institutional certification Genetic/Genomic Data Sharing: RMG Forms webpage



top Top

Quick Links to NIH websites

top Top

 

 

 


Institutional representatives (RMG & OSR) contact information


Institutional Representatives:
School of Medicine PIs:

PIs*: you do not have to submit your pre-application through your institutional representative.
*Exception: CE faculty must submit and obtain approval for a CE faculty PI waiver >> through their RPM in RMG >> prior to the pre-application submission.
Research Process Manager (RPM) department assignments >>
RMG internal proposal deadline policy, FAQs and best practices** webpage

For PIs in Other Schools:

Office of Sponsored Research (OSR) Contract and Grant Officer (CGO) department assignments;
Download the Pre-award assignment list from this DoResearch Office webpage >>

 


Top

Footer Links: